Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis.
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
Central remyelination restores secure conduction.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Emery-Dreifuss muscular dystrophy type 2 associated (?) with mild peripheral polyneuropathy.
Phenotyping primary human microglia: tight regulation of LPS responsiveness.
B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
Immunomodulation by vitamin D in multiple sclerosis: More than IL-17.
Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response.
Fatal herpes encephalitis in a patient with small cell lung cancer following prophylactic cranial radiation - a case report with review of literature.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Relapses in multiple sclerosis: Relationship to disability.
Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients.
The Aqueous Fraction of Areca catechu Nut Ameliorates Demyelination in Prefrontal Cortex-Induced Depressive Symptoms and Cognitive Decline through Brain-Derived Neurotrophic Factor-Cyclic Adenosine Monophosphate Response Element-Binding Activation.
Effects of vitamin D on the peripheral adaptive immune system: a review.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
Role of Pulmonary Evaluation in Diagnosis of Neurosarcoidosis.
Lung inflammation stalls Th17 cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.
Pages
« first
‹ previous
…
721
722
723
724
725
726
727
728
729
…
next ›
last »